Xifaxan
Product Images NDC 68151-4980

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Xifaxan (NDC 68151-4980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Figure3)

A clinical trial study design diagram labeled 'Figure 3: Trial 3 Study Design' showing multiple phases including screening/treatment, treatment phases 2 to 4, maintenance phases, and follow-up. It outlines timelines, treatment allocations, evaluations, and symptom diary data collection timepoints for study subjects.*

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of the active ingredient in XIFAXAN. The diagram shows the molecular arrangement, including rings and functional groups, of the compound's chemical structure as depicted in the image.*

FDA Label Image

Figure 1 (Image 02)

A Kaplan-Meier survival curve comparing XIFAXAN with placebo, showing the proportion of patients without breakthrough hepatic encephalopathy over days post-randomization. The graph includes hazard ratio, confidence interval, and p-value statistics demonstrating a significant difference between the two groups.*

FDA Label Image

Figure 2 (Image 03)

A Kaplan-Meier curve graph depicting the proportion of patients without HE-related hospitalization over time in days post-randomization. Two groups are compared: XIFAXAN and Placebo, with XIFAXAN showing a higher proportion over the study period. The graph includes a hazard ratio of 0.500, 95% confidence interval (0.287, 0.873), and a log-rank p-value of 0.0129.*

FDA Label Image

Label Image (Lbl681514980)

Label for XIFAXAN (rifaximin) 200 mg tablets showing the manufacturer as Salix, with lot number MDWB, expiration date 07/14, product code 4980, and a barcode with the number 0000004980. The label includes the statement RX ONLY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.